ATAT
Atour Lifestyle Holdings Limited
ATAT has the edge over LCID overall, supported by lower modeled downside and stronger fundamentals.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ATAT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
ATAT's revenue, profitability, cash flow and balance sheet are all currently strong.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ATAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $36.87 | — |
| Cheap | 18x | $37.84 | +2.6% |
| Fair | 25x | $53.81 | +46% |
| Expensive | 45x | $95.80 | +160% |
Historical ranges are pointers, not guarantees.
ATAT's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ATAT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ATAT, with profitability holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ATAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.12 | +42% |
| Q1 2026 | $1.98 | +46% |
| Q4 2025 | $1.74 | +46% |
| Q3 2025 | $1.58 | +72% |
| Q2 2025 | $1.49 | +91% |
| Q1 2025 | $1.36 | +92% |
| Q4 2024 | $1.19 | +86% |
| Q3 2024 | $0.92 | +100% |
ATAT has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ATAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $522.3M | +41% |
| Q1 2026 | $421.9M | +48% |
| Q4 2025 | $418.4M | +34% |
| Q3 2025 | $394.4M | +38% |
| Q2 2025 | $370.5M | +37% |
| Q1 2025 | $286M | +30% |
| Q4 2024 | $312.8M | +38% |
| Q3 2024 | $284.9M | +47% |
ATAT's revenue has grown year over year for 16 quarters in a row: $522M last quarter, up 41% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | -3.3 points |
| Q1 2026 | 24% | +4.9 points |
| Q4 2025 | 25% | +5.4 points |
| Q3 2025 | 25% | -1.1 points |
| Q2 2025 | 24% | +2.4 points |
| Q1 2025 | 19% | -3.5 points |
| Q4 2024 | 20% | +5.6 points |
| Q3 2024 | 26% | -0.4 points |
ATAT has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ATAT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ATAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $123.4M | +12% |
| Q1 2026 | $43M | +$45.6M |
| Q4 2025 | $85.2M | -0.9% |
| Q3 2025 | $90.8M | +48% |
| Q2 2025 | $110.7M | +33% |
| Q1 2025 | -$2.6M | -113% |
| Q4 2024 | $86M | +3.4% |
| Q3 2024 | $61.3M | -24% |
ATAT has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ATAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.7x | Net Cash |
ATAT has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ATAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.6 | Neutral |
| Stochastic | 68.9 | Neutral |
ATAT's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ATAT PE vs Consumer Cyclical Sector
| Metric | ATAT | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 3.5% below |
| PE % | 11 | 46 | 35 pts below |
ATAT is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ATAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.5 | 10% above |
| 20 week MA | $33.5 | 10% above |
| 50 week MA | $35.8 | 2.9% above |
| 100 week MA | $34.1 | 8.3% above |
| 200 week MA | $27.1 | 36% above |
ATAT has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ATAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $12.9 | $18.5 | +44% |
| 2023 | $18.5 | $17.4 | -6.2% |
| 2024 | $17.4 | $27.0 | +56% |
| 2025 | $27.0 | $41.7 | +55% |
| 2026 YTD | $41.7 | $36.9 | -12% |
ATAT has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.